Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
Trump
Administration
Supported by
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
By Rob Copeland and Rebecca Robbins
Major pharmaceutical giants have been buying rights to drugs developed in China for common diseases like obesity and heart…
President Trump's Most Favored Nation drug policy lowers costs, but Big Pharma spends millions to preserve high prices.
The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information…
The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower…
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on August 5.
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of…
Ministers scramble to gag drug giants amid fears of Trump tariff showdown
